Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-24 @ 10:57 PM
NCT ID:
NCT02644369
Brief Title:
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors
Official Title:
Investigator-initiated Phase II Study of Pembrolizumab Immunological Response Evaluation
Acronym:
INSPIRE
Study:
NCT02644369
Protocol Section:
NCT02644369